Spearheading TCS since he took over as CEO and MD in 2009, Chandra has shown he can take tough business decisions and challenge the status ...

A five-man panel that includes Ratan Tata, Mistry's predecessor and the interim chairman, has been tasked with finding a new chairman.

The stock is at rich valuations despite low sales and profit growth. The open offer by its parent firm is attractively priced, say experts.

Experts say investors should bet on companies that have the ability to raise prices and trade at reasonable valuations.

Majority of Indian pharmaceutical companies fear pressure on profit margins by at least 300-400 basis points as Andhra Pradesh, which accou...

The Budget propsal is seen more to preserve a critical raw material for Indian steel companies that have announced expansion plans which wo...

In spite of challenging market conditions, more and more Indian pharma companies are entering the US generic drugs market.

With anti-cancer blockbuster drugs set to go off-patent in the US in the next three to four years, generic players are gearing up to tap th...